The cost of treatment with redecision COVID-19 will be 2340 dollars
Gilead announced the pricing of ramdevpir: in the US the treatment of one patient with coronavirus new drug will cost 2340 dollars. One vial of the drug in the United States and for governments in developing countries will cost $ 390, while American insurance companies have to pay 520 dollars for a bottle (and 3120 dollars for a five-day course), writes Reuters.
Antiretroviral ramdevpir was the first drug that demonstrated in clinical studies its effectiveness in the treatment of coronavirus infection. Gilead has already signed an agreement with the U.S. government on the use of ramdevpir therapy COVID-19, the agreement will be valid until the end of September 2020.
Currently, medicine is available in form for intravenous injection, however, in August 2020 Gilead intends to begin clinical trials more easy to use form LS – inhalation.
